daily oral glp-1 receptor agonist orforglipron for adults with obesity A new medication can help and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the FDA Grants Speedy Approval to

MASLD / Liver Research Metabolic dysfunction-associated steatotic liver disease is under Phase 3 evaluation

The ongoing dedicated ophthalmic trial named as FOCUS study, which aims to evaluate semaglutides long-term effects on diabetic retinopathy, is now ongoing and could contribute to a comprehensive understanding of the true risk-benefit profile of these agents in patients with or at risk for diabetic retinopathy (NCT03811561) [104]

Make the most of retailer deals If you need to take B12 supplements regularly, look out for multi-buy offers which can bring the cost down

prescription drugs by sales are largely expensive, specialized therapies (often biologics) for serious chronic illnesses (cancer, diabetes/obesity, autoimmune disease, etc.)

They've got a great experience in this kind of area and a great network of key opinion leaders and experts who can give counsel on this data

What about TB-500, GHK-Cu, Melanotan II, and Epithalon